[
    {
        "file_name": "MIDDLEBROOKPHARMACEUTICALS,INC_03_18_2010-EX-10.1-PROMOTIONAGREEMENT.txt",
        "perturbation": [
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "DD shall use commercially reasonable efforts to promote MOXATAG to DD Target Segment Prescribers and agrees  to efficiently perform the services as described in EXHIBIT 4 in compliance with MBRK's policies and procedures, and  all applicable federal and state laws and regulations, including, without limitation, federal and state anti-kickback  statutes, regulations contained in 21 CFR (Code of Federal Regulations) as they pertain to promotional activity of an  FDA-approved pharmaceutical product and the US Department of Health and Human Services Office of Inspector General's (\"OIG\") Compliance Program Guidance for Pharmaceutical Manufacturers (2003). DD agrees that it shall not  directly or indirectly offer, pay or transfer anything of value, in cash or in-kind, to induce DD Target Segment Prescribers  to purchase, order, or recommend MOXATAG, nor shall DD exert undue influence on the medical decision-making of  DD Target Segment Prescribers.",
                "changed_text": "DD shall use commercially reasonable efforts to promote MOXATAG to DD Target Segment Prescribers and agrees  to efficiently perform the services as described in EXHIBIT 4 in compliance with MBRK's policies and procedures. DD agrees that it shall not  directly or indirectly offer, pay or transfer anything of value, in cash or in-kind, to induce DD Target Segment Prescribers  to purchase, order, or recommend MOXATAG, nor shall DD exert undue influence on the medical decision-making of  DD Target Segment Prescribers.",
                "explanation": "Removing the phrase 'all applicable federal and state laws and regulations, including, without limitation, federal and state anti-kickback statutes, regulations contained in 21 CFR (Code of Federal Regulations) as they pertain to promotional activity of an FDA-approved pharmaceutical product and the US Department of Health and Human Services Office of Inspector General's (\"OIG\") Compliance Program Guidance for Pharmaceutical Manufacturers (2003)' weakens DD's legal obligation to comply with these specific regulations, potentially leading to legal issues if DD violates these regulations. The contract now does not explicitly state these protections.",
                "contradicted_law": "Federal Anti-Kickback Statute, 42 U.S.C. ยง 1320a-7b(b); 21 CFR (Code of Federal Regulations) pertaining to promotional activity of FDA-approved pharmaceuticals; US Department of Health and Human Services OIG Compliance Program Guidance for Pharmaceutical Manufacturers (2003)",
                "location": "Section 3.5"
            },
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "Each Party represents and warrants that it shall comply in all material respects with any and all applicable federal,  state, and local laws and regulations and industry guidances and standards applicable to the conduct of business and  the execution of any and all marketing and promotional services or activities pursuant to this Agreement, including but  not limited to: the federal anti-kickback statute, 42 U.S.C. ยง 1320a-7b(b); federal Food, Drug and Cosmetic Act and  relevant regulations; FDA promotional guidelines; FDA's Guidance on Industry-Supported Scientific and Educational  Activities (1997); US Department of Health and Human Services OIG Compliance Program Guidance for Pharmaceutical  Manufacturers (2003); the Pharmaceutical Research and Manufacturers of America (\"PhRMA\")  Code on Interactions  With Healthcare Professionals; and ethics opinions of the American Medical Association (\"AMA\").",
                "changed_text": "Each Party represents and warrants that it shall comply in all material respects with any and all applicable federal,  state, and local laws and regulations and industry guidances and standards applicable to the conduct of business and  the execution of any and all marketing and promotional services or activities pursuant to this Agreement.",
                "explanation": "By removing the enumerated list of laws and guidelines like the federal anti-kickback statute and FDA promotional guidelines, the contract is weakened. Although there is a general statement about compliance, there is no specific mention of those protections. This change introduces legal risk.",
                "contradicted_law": "Federal Anti-Kickback Statute, 42 U.S.C. ยง 1320a-7b(b); Federal Food, Drug and Cosmetic Act; FDA promotional guidelines; FDA's Guidance on Industry-Supported Scientific and Educational Activities (1997); US Department of Health and Human Services OIG Compliance Program Guidance for Pharmaceutical Manufacturers (2003); PhRMA Code on Interactions With Healthcare Professionals; AMA ethics opinions.",
                "location": "Section 8.2"
            },
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "Each Party represents and warrants that it shall comply with any and all applicable federal, state, and local laws  and regulations including, but not limited to, health, safety and security rules and regulations and all privacy laws and  regulations, including but not limited to applicable state privacy laws and regulations and the privacy requirements set  forth in the Health Insurance Portability and Accountability Act (HIPAA).",
                "changed_text": "Each Party represents and warrants that it shall comply with any and all applicable federal, state, and local laws  and regulations including health, safety and security rules and regulations and privacy laws and regulations.",
                "explanation": "By removing \"but not limited to, applicable state privacy laws and regulations and the privacy requirements set forth in the Health Insurance Portability and Accountability Act (HIPAA)\", the contract now has weakened security towards HIPAA. This creates a loophole.",
                "contradicted_law": "Health Insurance Portability and Accountability Act (HIPAA)",
                "location": "Section 8.4"
            }
        ]
    }
]